BioLargo (BLGO) Competitors $0.16 -0.01 (-5.75%) As of 11:19 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BLGO vs. AMTX, VGAS, LODE, FSI, ZTEK, TSE, ALTO, ORGN, LOOP, and CBUSShould you be buying BioLargo stock or one of its competitors? The main competitors of BioLargo include Aemetis (AMTX), Verde Clean Fuels (VGAS), Comstock (LODE), Flexible Solutions International (FSI), Zentek (ZTEK), Trinseo (TSE), Alto Ingredients (ALTO), Origin Materials (ORGN), Loop Industries (LOOP), and Cibus (CBUS). These companies are all part of the "chemicals" industry. BioLargo vs. Its Competitors Aemetis Verde Clean Fuels Comstock Flexible Solutions International Zentek Trinseo Alto Ingredients Origin Materials Loop Industries Cibus BioLargo (NASDAQ:BLGO) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends and media sentiment. Which has better earnings & valuation, BLGO or AMTX? BioLargo has higher earnings, but lower revenue than Aemetis. BioLargo is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLargo$12.23M3.95-$3.50M-$0.01-15.58Aemetis$267.64M0.72-$87.54M-$1.62-1.89 Which has more volatility & risk, BLGO or AMTX? BioLargo has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, Aemetis has a beta of 1.68, suggesting that its share price is 68% more volatile than the S&P 500. Do analysts recommend BLGO or AMTX? Aemetis has a consensus price target of $17.33, indicating a potential upside of 467.38%. Given Aemetis' stronger consensus rating and higher probable upside, analysts plainly believe Aemetis is more favorable than BioLargo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aemetis 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50 Is BLGO or AMTX more profitable? BioLargo has a net margin of -11.45% compared to Aemetis' net margin of -36.70%. Aemetis' return on equity of 0.00% beat BioLargo's return on equity.Company Net Margins Return on Equity Return on Assets BioLargo-11.45% -39.90% -22.06% Aemetis -36.70%N/A -33.18% Do institutionals and insiders hold more shares of BLGO or AMTX? 0.0% of BioLargo shares are held by institutional investors. Comparatively, 27.0% of Aemetis shares are held by institutional investors. 19.3% of BioLargo shares are held by insiders. Comparatively, 15.9% of Aemetis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media prefer BLGO or AMTX? In the previous week, Aemetis had 5 more articles in the media than BioLargo. MarketBeat recorded 6 mentions for Aemetis and 1 mentions for BioLargo. Aemetis' average media sentiment score of 0.40 beat BioLargo's score of 0.00 indicating that Aemetis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLargo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aemetis 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryAemetis beats BioLargo on 10 of the 16 factors compared between the two stocks. Get BioLargo News Delivered to You Automatically Sign up to receive the latest news and ratings for BLGO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLGO vs. The Competition Export to ExcelMetricBioLargoChemicals & allied products IndustryConstruction SectorNASDAQ ExchangeMarket Cap$48.34M$11.86B$9.74B$10.57BDividend YieldN/A1.09%1.89%4.70%P/E Ratio-15.58N/A17.4127.08Price / Sales3.953.12102.90204.46Price / CashN/A14.8015.7131.09Price / Book15.589.444.806.66Net Income-$3.50M$989.69M$625.65M$275.86M7 Day Performance-12.96%-5.31%0.66%3.06%1 Month Performance-28.86%-13.47%-0.15%10.52%1 Year Performance-35.06%-16.65%109.20%33.54% BioLargo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLGOBioLargo0.4648 of 5 stars$0.16-5.7%N/A-31.1%$48.34M$12.23M-15.5830Gap DownAMTXAemetis1.998 of 5 stars$2.25-3.0%$17.00+655.6%-2.6%$146.72M$223.57M-1.39160Positive NewsAnalyst ForecastVGASVerde Clean FuelsN/A$3.05-1.9%N/A-19.2%$138.55MN/A-7.442LODEComstock0.8944 of 5 stars$3.42-3.4%$4.00+17.0%-32.1%$122.88M$3.28M-28.5030FSIFlexible Solutions International3.8465 of 5 stars$9.64+3.4%N/A+182.3%$117.96M$37.32M29.2140Gap DownZTEKZentek0.3792 of 5 stars$0.77-8.0%N/A+18.0%$87.17M$1.22M-15.3224News CoverageShort Interest ↑Gap UpTSETrinseo0.7785 of 5 stars$2.35-0.8%N/A-65.6%$85.21M$3.26B-0.212,950News CoverageALTOAlto Ingredients3.2169 of 5 stars$1.08-0.9%$5.50+409.3%-33.1%$84.36M$965.26M-1.17420News CoveragePositive NewsORGNOrigin Materials2.2075 of 5 stars$0.52+5.2%$1.50+189.2%-64.2%$73.93M$31.28M-0.84160Positive NewsLOOPLoop Industries1.0787 of 5 stars$1.48-2.6%N/A-3.0%$72.53M$10.89M-5.2990CBUSCibus2.2536 of 5 stars$1.29-1.5%$21.25+1,547.3%-52.8%$71.05M$4.85M-0.1248 Related Companies and Tools Related Companies AMTX Competitors VGAS Competitors LODE Competitors FSI Competitors ZTEK Competitors TSE Competitors ALTO Competitors ORGN Competitors LOOP Competitors CBUS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLGO) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored"I'm risking my reputation on this"My prediction: Q4 2025 won't just be another seasonal crypto pump. It will be the quarter that sparks a crypto...Crypto 101 Media | SponsoredWall Street legend: “Sell this A.I. stock now”Whats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredThe next wave of AI fortunes may come from NVIDIA’s secret supplier.Bloomberg says AI is a $50 trillion revolution. And at the center of it… isn't NVIDIA. It's a tiny suppl...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLargo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLargo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
